1. Home
  2. ONEG vs HURA Comparison

ONEG vs HURA Comparison

Compare ONEG & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONEG
  • HURA
  • Stock Information
  • Founded
  • ONEG 2021
  • HURA 2009
  • Country
  • ONEG Hong Kong
  • HURA United States
  • Employees
  • ONEG N/A
  • HURA N/A
  • Industry
  • ONEG Homebuilding
  • HURA
  • Sector
  • ONEG Consumer Discretionary
  • HURA
  • Exchange
  • ONEG Nasdaq
  • HURA Nasdaq
  • Market Cap
  • ONEG 156.2M
  • HURA 131.8M
  • IPO Year
  • ONEG 2024
  • HURA N/A
  • Fundamental
  • Price
  • ONEG $5.30
  • HURA $2.12
  • Analyst Decision
  • ONEG
  • HURA Strong Buy
  • Analyst Count
  • ONEG 0
  • HURA 2
  • Target Price
  • ONEG N/A
  • HURA $11.50
  • AVG Volume (30 Days)
  • ONEG 464.2K
  • HURA 179.3K
  • Earning Date
  • ONEG 08-12-2025
  • HURA 11-14-2025
  • Dividend Yield
  • ONEG N/A
  • HURA N/A
  • EPS Growth
  • ONEG N/A
  • HURA N/A
  • EPS
  • ONEG 0.08
  • HURA N/A
  • Revenue
  • ONEG $53,205,000.00
  • HURA N/A
  • Revenue This Year
  • ONEG N/A
  • HURA N/A
  • Revenue Next Year
  • ONEG N/A
  • HURA N/A
  • P/E Ratio
  • ONEG $133.52
  • HURA N/A
  • Revenue Growth
  • ONEG N/A
  • HURA N/A
  • 52 Week Low
  • ONEG $1.48
  • HURA $1.80
  • 52 Week High
  • ONEG $13.50
  • HURA $7.20
  • Technical
  • Relative Strength Index (RSI)
  • ONEG 19.35
  • HURA 32.79
  • Support Level
  • ONEG $9.00
  • HURA $2.01
  • Resistance Level
  • ONEG $10.82
  • HURA $2.60
  • Average True Range (ATR)
  • ONEG 1.42
  • HURA 0.15
  • MACD
  • ONEG -0.32
  • HURA -0.04
  • Stochastic Oscillator
  • ONEG 13.43
  • HURA 8.84

About ONEG OneConstruction Group Limited Ordinary Shares

OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: